secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2022-08-24T23:59:59+00:00
Accession:  0001193125-22-228064
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences voluntarily recalls all CereLink ICP monitors; cuts guidance by $9M
--------------------------------------------------------------------------------

- Voluntary global removal of all CereLink intracranial pressure monitors due to out-of-range readings from electrical interference.
- Records $9M returns provision in Q3 2022; Q3 revenue guidance lowered to $374-382M from $383-391M.
- Full-year revenue guidance reduced to $1,548-1,566M from $1,557-1,575M; adjusted EPS lowered to $3.12-3.20 from $3.21-3.29.
- Low incidence rate at limited sites; investigation ongoing; plans to resume shipments after resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/0001193125-22-228064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/d366857d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-228064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer